MedPage Today on MSN8h
Varipulse Returns; HCM Genes Reconsidered; Early Blood Test for Preeclampsia?To predict arrhythmic risk in carriers of filamin C truncating variants, a novel risk predictive model was developed based on ...
News Medical on MSN4d
A step toward precision medicine: New drug targets for heart failureA groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...
A novel transcatheter-implanted system that shunts blood flow from the left to right atrium through the coronary sinus has ...
Slower gait speed, but not handgrip strength or muscle mass, is associated with an increased risk for cardiovascular outcomes ...
February 17, 2025 - DALLAS The International Consortium for Health Outcomes Measurement (ICHOM) has developed a globally ...
There is an unmet need for therapies targeting Duchenne muscular dystrophy (DMD)–related heart disease, and phase 2 results ...
Bayer seeks Japanese marketing approval for finerenone to treat adult patients with chronic heart failure: Berlin Saturday, February 15, 2025, 14:00 Hrs [IST] Bayer announced the ...
A recent study from the FINEARTS-HF trial revealed that finerenone, which is an oral mineralocorticoid receptor antagonist, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback